Pediatric advance care planning linked to better understanding of child's end-of-life care choices

October 19, 2018

WASHINGTON-The more that families understand the end-of-life treatment preferences expressed by adolescents living with human immunodeficiency virus (HIV), the less likely these youth are to suffer HIV-related symptoms compared with youths whose families do not understand their end-of-life care goals, according to a single-blinded, randomized study published online Oct. 19, 2018, in Pediatrics. And when families struggle to understand their child's end-of-life care choices, that is associated with a higher likelihood of HIV-positive adolescents suffering physical symptoms, including pain.

While overall new HIV infections dropped in Washington from 2013 to 2017, there was an increase in new HIV diagnoses among young people aged 13 to 29, according to DC Health. And despite the advent of highly effective medications, U.S. youth living with HIV/AIDS are six to 12 times more likely to die than the general public, the new research paper notes.

In that study, a multi-institutional research team spent five years quantifying the relationship between FAmily CEntered (FACE) pediatric advance care planning and HIV-specific symptoms experienced by youths, building on earlier results from a small randomized trial. From July 2011 to June 2014, they enrolled 105 HIV-positive youth receiving treatment at HIV clinics based at six U.S. hospitals and their families.

The patients' mean age was 17.8 years (range 14 to 21 years). Fifty-four percent were male; 93 percent were African American; 55 percent had viral suppression. Family member's mean age was 45. Eighty-two percent were female, and 90 percent were African American. One-third of family participants reported being HIV-positive themselves.

The patients and families received three, 60-minute FACE sessions weekly that included completing an advance care planning survey, having conversations about care goals in order to create advance care plans using the adapted "Next Steps: Respecting Choices" interview and by discussing the "Five Wishes" document.

End-of-life treatment preferences included:"Controlling for age, parental education, family income and other variables, family members who participated in FACE were more likely to understand their child's end-of-life care goals, which significantly reduced the adolescents' physical symptoms, like pain, up to 12 months later," says Maureen E. Lyon, Ph.D., ABPP, a clinical health psychologist at Children's National Health System and the study's lead author. "A greater degree of familial understanding suggests good communication and social support, which already has been demonstrated to decrease HIV-specific symptoms in adults."

According to the research team, participating in pediatric advance care planning conferred a sense of control for youths living with HIV, which is associated with reduced physical symptoms, especially pain. Two mechanisms exerted a particularly powerful effect, Lyon adds: Satisfying social support by way of respectful and authentic conversations and making choices about treatments with parental support when outcomes were poor, such as facing the prospect of lengthy hospitalization, multiple procedures and a slim chance of survival.

"Our results underscore the potential to improve patients' quality of life by offering pediatric advance care planning in HIV clinics based at pediatric hospitals," Lyon says. "In addition, these findings could inform best practices for caring for pediatric patients who are contending with other serious, life-threatening illnesses."

In future research, the team will explore why families who were highly religious correlates with a higher likelihood of youths experiencing more HIV-specific symptoms. They assessed the health-relevant domains of religiousness/spirituality by using a validated tool to ask such questions as whether the family member feels "God's presence," how often they prayed privately or attended religious services, and whether they considered themselves to be a religious or spiritual person.
In addition to Lyon, additional Children's study authors include Lawrence J. D'Angelo, M.D., MPH; Ronald H. Dallas, Ph.D.; Yao I. Cheng, MS; and Senior Study Author and Biostatistician Jichuan Wang, Ph.D., for the Adolescent Palliative Care Consortium; with co-authors Patricia A. Garvie, Ph.D., of Children's Diagnostic & Treatment Center; Linda Briggs, MA, MS, RN, of Respecting Choices: A Division of Coalition to Transform Advanced Care Innovations; Patricia M. Flynn, M.D., of St. Jude Children's Research Hospital; and Ana Garcia, Ph.D., LCSW, University of Miami Miller School of Medicine.

Research reported in this news release was supported by the National Institute of Nursing Research under award number R01NR012711-05 and the National Institutes of Health National Center for Advancing Translational Sciences under award number CTSI-CN UL1TR000075.

Children's National Health System

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to